Boxer Capital Management’s F-star Therapeutics FSTX Stock Holding History
Bought
Maintained
Sold
Other funds holding FSTX
RCI
Boxer Capital Management's FSTX Position: Q4 2021 in Review
Boxer Capital Management sold out of F-star Therapeutics (FSTX) in Q4 2021, closing a stake of 1,751,428 shares — an estimated $12.8M sold.
Boxer Capital Management first reported a position in FSTX in Q2 2021 and held it in 2 quarters. The position peaked at $15M in Q2 2021. 43 funds tracked by Wall St. Rank hold FSTX as of Q4 2021.
- Boxer Capital Management reported no remaining F-star Therapeutics position as of Q4 2021 after selling out during the quarter.
- Boxer Capital Management sold 1,751,428 F-star Therapeutics shares in Q4 2021, an estimated $12.8M.
- Boxer Capital Management first reported a position in F-star Therapeutics in Q2 2021 and held it in 2 quarters.
- Boxer Capital Management's F-star Therapeutics position peaked at $15M in Q2 2021.
- 43 funds tracked by Wall St. Rank held F-star Therapeutics as of Q4 2021.
Based on Boxer Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.